Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Teva
Merck
Novartis
QuintilesIMS
Medtronic
Julphar
AstraZeneca
Deloitte

Generated: February 20, 2018

DrugPatentWatch Database Preview

NOVOLOG MIX 50/50 Drug Profile

« Back to Dashboard

Which patents cover Novolog Mix 50/50, and when can generic versions of Novolog Mix 50/50 launch?

Novolog Mix 50/50 is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in NOVOLOG MIX 50/50 is insulin aspart protamine recombinant; insulin aspart recombinant. There are thirty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin aspart protamine recombinant; insulin aspart recombinant profile page.
Summary for NOVOLOG MIX 50/50
US Patents:0
Applicants:1
NDAs:1
Clinical Trials:48
Drug Prices:see details
DailyMed Link:NOVOLOG MIX 50/50 at DailyMed
Drug patent expirations by year for NOVOLOG MIX 50/50

US Patents and Regulatory Information for NOVOLOG MIX 50/50

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc NOVOLOG MIX 50/50 insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021810-001 Aug 26, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NOVOLOG MIX 50/50

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Moodys
Farmers Insurance
Johnson and Johnson
Mallinckrodt
Cerilliant
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot